The Effect of Vitamin Therapy on the Progression of Coronary Artery Atherosclerosis Varies by Haptoglobin Type in Postmenopausal Women
Andrew P. Levy(Technion – Israel Institute of Technology), Barbara V. Howard(MedStar Health), Jean‐Claude Tardif(Montreal Heart Institute), Paula Friedenberg(George Washington University), Pamela Ouyang(Johns Hopkins University), Vera Bittner(University of Alabama at Birmingham), Mark Tripputi(George Washington University), Frederick R. Cobb(Duke University), Lyall Higginson(University of Ottawa), Rachel Lotan(Technion – Israel Institute of Technology)
Cited by 52
Related Papers
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k